Home > Healthcare > Biotechnology > Biopharma > Monoclonal Antibodies Market

Monoclonal Antibodies Market Share

Report ID: GMI5065
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Monoclonal Antibodies Market Share

Some of notable key players operating in the monoclonal antibodies market including

AbbVie Inc.
F. Hoffmann-La Roche
Amgen Inc.
Bristol Myers Squibb
Johnson & Johnson
Merck & Co., Inc.
Regeneron Pharmaceuticals Inc.
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Novartis AG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for monoclonal antibodies surpassed USD 186.6 billion in 2022 and is estimated to exceed USD 609 billion by 2032 driven by the increasing prevalence of chronic and infectious diseases along with growing number of R&D activities

Fully human monoclonal antibodies industry held 50.8% revenue share in 2022 and is estimated to witness high demand through 2032 attributed to the increasing number of product approvals and drug launches of fully human monoclonal antibodies.

North America recorded more than 48.8% share of the market in 2022 and is poised to record substantial growth between 2023 and 2032 attributed to the strong presence of key business players and the rising number of product approvals.

Some of the major companies operating in the industry are AbbVie Inc., F. Hoffmann-La Roche, Bristol Myers Squibb, Amgen Inc., Bristol Myers Squibb, Johnson & Johnson, Merck & Co., Inc., Regeneron Pharmaceuticals Inc., AstraZeneca, Eli Lilly and Company, and GlaxoSmithKline plc,